nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP3A4—Pilocarpine—glaucoma	0.0476	0.236	CbGbCtD
Danazol—CYP3A4—Brinzolamide—glaucoma	0.0373	0.185	CbGbCtD
Danazol—CYP3A4—Dorzolamide—glaucoma	0.0361	0.178	CbGbCtD
Danazol—CYP3A4—Methazolamide—glaucoma	0.0322	0.159	CbGbCtD
Danazol—CYP3A4—Acetazolamide—glaucoma	0.0257	0.127	CbGbCtD
Danazol—CYP3A4—Clonidine—glaucoma	0.0232	0.115	CbGbCtD
Danazol—Cortisone acetate—NR3C1—glaucoma	0.00167	0.25	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—glaucoma	0.00109	0.164	CrCbGaD
Danazol—Prednisone—NR3C1—glaucoma	0.000943	0.141	CrCbGaD
Danazol—Progesterone—CYP1B1—glaucoma	0.000911	0.136	CrCbGaD
Danazol—Dizziness—Levobunolol—glaucoma	0.000899	0.00163	CcSEcCtD
Danazol—Tremor—Pilocarpine—glaucoma	0.000897	0.00163	CcSEcCtD
Danazol—Palpitations—Dorzolamide—glaucoma	0.000895	0.00163	CcSEcCtD
Danazol—Vertigo—Brinzolamide—glaucoma	0.000895	0.00163	CcSEcCtD
Danazol—Pruritus—Latanoprost—glaucoma	0.000892	0.00162	CcSEcCtD
Danazol—Rash—Diclofenamide—glaucoma	0.000892	0.00162	CcSEcCtD
Danazol—Palpitations—Travoprost—glaucoma	0.000891	0.00162	CcSEcCtD
Danazol—Loss of consciousness—Dorzolamide—glaucoma	0.00089	0.00162	CcSEcCtD
Danazol—Affect lability—Timolol—glaucoma	0.000889	0.00161	CcSEcCtD
Danazol—Shock—Acetazolamide—glaucoma	0.000887	0.00161	CcSEcCtD
Danazol—Headache—Diclofenamide—glaucoma	0.000887	0.00161	CcSEcCtD
Danazol—Thrombocytopenia—Acetazolamide—glaucoma	0.000883	0.0016	CcSEcCtD
Danazol—Palpitations—Brinzolamide—glaucoma	0.00088	0.0016	CcSEcCtD
Danazol—Vomiting—Carbachol—glaucoma	0.000878	0.0016	CcSEcCtD
Danazol—Hypertension—Dorzolamide—glaucoma	0.000875	0.00159	CcSEcCtD
Danazol—Rash—Carbachol—glaucoma	0.000871	0.00158	CcSEcCtD
Danazol—Hypertension—Travoprost—glaucoma	0.000871	0.00158	CcSEcCtD
Danazol—Dermatitis—Carbachol—glaucoma	0.00087	0.00158	CcSEcCtD
Danazol—Fatigue—Apraclonidine—glaucoma	0.000869	0.00158	CcSEcCtD
Danazol—Weight increased—Betaxolol—glaucoma	0.000869	0.00158	CcSEcCtD
Danazol—Oedema—Brimonidine—glaucoma	0.000866	0.00157	CcSEcCtD
Danazol—Headache—Carbachol—glaucoma	0.000865	0.00157	CcSEcCtD
Danazol—Arthralgia—Dorzolamide—glaucoma	0.000862	0.00157	CcSEcCtD
Danazol—Constipation—Apraclonidine—glaucoma	0.000862	0.00157	CcSEcCtD
Danazol—Testosterone—CYP1B1—glaucoma	0.000861	0.129	CrCbGaD
Danazol—Dyspepsia—Bimatoprost—glaucoma	0.000861	0.00156	CcSEcCtD
Danazol—Hypertension—Brinzolamide—glaucoma	0.00086	0.00156	CcSEcCtD
Danazol—Anxiety—Dorzolamide—glaucoma	0.000859	0.00156	CcSEcCtD
Danazol—Arthralgia—Travoprost—glaucoma	0.000859	0.00156	CcSEcCtD
Danazol—Syncope—Pilocarpine—glaucoma	0.000858	0.00156	CcSEcCtD
Danazol—Leukopenia—Pilocarpine—glaucoma	0.000857	0.00156	CcSEcCtD
Danazol—Anxiety—Travoprost—glaucoma	0.000856	0.00155	CcSEcCtD
Danazol—Mood swings—Timolol—glaucoma	0.000855	0.00155	CcSEcCtD
Danazol—Nausea—Carteolol—glaucoma	0.000855	0.00155	CcSEcCtD
Danazol—Headache—Levobunolol—glaucoma	0.000852	0.00155	CcSEcCtD
Danazol—Shock—Brimonidine—glaucoma	0.000852	0.00155	CcSEcCtD
Danazol—Arthralgia—Brinzolamide—glaucoma	0.000848	0.00154	CcSEcCtD
Danazol—Palpitations—Pilocarpine—glaucoma	0.000846	0.00154	CcSEcCtD
Danazol—Tachycardia—Brimonidine—glaucoma	0.000845	0.00154	CcSEcCtD
Danazol—Loss of consciousness—Pilocarpine—glaucoma	0.000841	0.00153	CcSEcCtD
Danazol—Nausea—Diclofenamide—glaucoma	0.000841	0.00153	CcSEcCtD
Danazol—Acute coronary syndrome—Betaxolol—glaucoma	0.000839	0.00153	CcSEcCtD
Danazol—Myocardial infarction—Betaxolol—glaucoma	0.000835	0.00152	CcSEcCtD
Danazol—Dizziness—Latanoprost—glaucoma	0.000834	0.00152	CcSEcCtD
Danazol—Vomiting—Methazolamide—glaucoma	0.000828	0.00151	CcSEcCtD
Danazol—Oedema—Dorzolamide—glaucoma	0.000827	0.0015	CcSEcCtD
Danazol—Hypertension—Pilocarpine—glaucoma	0.000826	0.0015	CcSEcCtD
Danazol—Abdominal pain upper—Timolol—glaucoma	0.000825	0.0015	CcSEcCtD
Danazol—Oedema—Travoprost—glaucoma	0.000823	0.0015	CcSEcCtD
Danazol—Rash—Methazolamide—glaucoma	0.000822	0.00149	CcSEcCtD
Danazol—Dermatitis—Methazolamide—glaucoma	0.000821	0.00149	CcSEcCtD
Danazol—Nausea—Carbachol—glaucoma	0.00082	0.00149	CcSEcCtD
Danazol—Sweating—Betaxolol—glaucoma	0.000816	0.00148	CcSEcCtD
Danazol—Headache—Methazolamide—glaucoma	0.000816	0.00148	CcSEcCtD
Danazol—Arthralgia—Pilocarpine—glaucoma	0.000815	0.00148	CcSEcCtD
Danazol—Shock—Dorzolamide—glaucoma	0.000813	0.00148	CcSEcCtD
Danazol—Anxiety—Pilocarpine—glaucoma	0.000812	0.00148	CcSEcCtD
Danazol—Paraesthesia—Acetazolamide—glaucoma	0.00081	0.00147	CcSEcCtD
Danazol—Nausea—Levobunolol—glaucoma	0.000808	0.00147	CcSEcCtD
Danazol—Tachycardia—Travoprost—glaucoma	0.000803	0.00146	CcSEcCtD
Danazol—Hyperhidrosis—Dorzolamide—glaucoma	0.000799	0.00145	CcSEcCtD
Danazol—Rash—Latanoprost—glaucoma	0.000795	0.00145	CcSEcCtD
Danazol—Dermatitis—Latanoprost—glaucoma	0.000795	0.00144	CcSEcCtD
Danazol—Dyspepsia—Acetazolamide—glaucoma	0.000794	0.00144	CcSEcCtD
Danazol—Tachycardia—Brinzolamide—glaucoma	0.000793	0.00144	CcSEcCtD
Danazol—Headache—Latanoprost—glaucoma	0.00079	0.00144	CcSEcCtD
Danazol—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000789	0.00143	CcSEcCtD
Danazol—Oedema—Pilocarpine—glaucoma	0.000781	0.00142	CcSEcCtD
Danazol—Fatigue—Acetazolamide—glaucoma	0.000778	0.00141	CcSEcCtD
Danazol—Paraesthesia—Brimonidine—glaucoma	0.000777	0.00141	CcSEcCtD
Danazol—Alopecia—Clonidine—glaucoma	0.000776	0.00141	CcSEcCtD
Danazol—Nausea—Methazolamide—glaucoma	0.000774	0.00141	CcSEcCtD
Danazol—Shock—Pilocarpine—glaucoma	0.000769	0.0014	CcSEcCtD
Danazol—Thrombocytopenia—Pilocarpine—glaucoma	0.000765	0.00139	CcSEcCtD
Danazol—Tachycardia—Pilocarpine—glaucoma	0.000762	0.00139	CcSEcCtD
Danazol—Dyspepsia—Brimonidine—glaucoma	0.000762	0.00138	CcSEcCtD
Danazol—Hyperhidrosis—Pilocarpine—glaucoma	0.000755	0.00137	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000753	0.00137	CcSEcCtD
Danazol—Tension—Clonidine—glaucoma	0.00075	0.00136	CcSEcCtD
Danazol—Musculoskeletal discomfort—Travoprost—glaucoma	0.00075	0.00136	CcSEcCtD
Danazol—Fatigue—Brimonidine—glaucoma	0.000746	0.00136	CcSEcCtD
Danazol—Nervousness—Clonidine—glaucoma	0.000742	0.00135	CcSEcCtD
Danazol—Paraesthesia—Dorzolamide—glaucoma	0.000742	0.00135	CcSEcCtD
Danazol—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000741	0.00135	CcSEcCtD
Danazol—Visual impairment—Betaxolol—glaucoma	0.000737	0.00134	CcSEcCtD
Danazol—Muscle spasms—Clonidine—glaucoma	0.000735	0.00134	CcSEcCtD
Danazol—Paraesthesia—Brinzolamide—glaucoma	0.00073	0.00133	CcSEcCtD
Danazol—Dyspepsia—Dorzolamide—glaucoma	0.000728	0.00132	CcSEcCtD
Danazol—Dyspepsia—Travoprost—glaucoma	0.000725	0.00132	CcSEcCtD
Danazol—Asthenia—Apraclonidine—glaucoma	0.000723	0.00131	CcSEcCtD
Danazol—Vision blurred—Clonidine—glaucoma	0.00072	0.00131	CcSEcCtD
Danazol—Urticaria—Acetazolamide—glaucoma	0.000717	0.0013	CcSEcCtD
Danazol—Tremor—Clonidine—glaucoma	0.000716	0.0013	CcSEcCtD
Danazol—Dyspepsia—Brinzolamide—glaucoma	0.000715	0.0013	CcSEcCtD
Danazol—Pruritus—Apraclonidine—glaucoma	0.000713	0.0013	CcSEcCtD
Danazol—Body temperature increased—Acetazolamide—glaucoma	0.000713	0.0013	CcSEcCtD
Danazol—Fatigue—Dorzolamide—glaucoma	0.000713	0.0013	CcSEcCtD
Danazol—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000712	0.00129	CcSEcCtD
Danazol—Fatigue—Travoprost—glaucoma	0.00071	0.00129	CcSEcCtD
Danazol—Flushing—Betaxolol—glaucoma	0.00071	0.00129	CcSEcCtD
Danazol—Constipation—Travoprost—glaucoma	0.000704	0.00128	CcSEcCtD
Danazol—Paraesthesia—Pilocarpine—glaucoma	0.000701	0.00127	CcSEcCtD
Danazol—Asthenia—Bimatoprost—glaucoma	0.000701	0.00127	CcSEcCtD
Danazol—Fatigue—Brinzolamide—glaucoma	0.000701	0.00127	CcSEcCtD
Danazol—Pruritus—Bimatoprost—glaucoma	0.000692	0.00126	CcSEcCtD
Danazol—Dyspepsia—Pilocarpine—glaucoma	0.000688	0.00125	CcSEcCtD
Danazol—Chills—Betaxolol—glaucoma	0.000686	0.00125	CcSEcCtD
Danazol—Syncope—Clonidine—glaucoma	0.000685	0.00125	CcSEcCtD
Danazol—Alopecia—Betaxolol—glaucoma	0.000676	0.00123	CcSEcCtD
Danazol—Palpitations—Clonidine—glaucoma	0.000676	0.00123	CcSEcCtD
Danazol—Loss of consciousness—Clonidine—glaucoma	0.000672	0.00122	CcSEcCtD
Danazol—Constipation—Pilocarpine—glaucoma	0.000668	0.00121	CcSEcCtD
Danazol—Sweating—Timolol—glaucoma	0.000667	0.00121	CcSEcCtD
Danazol—Dizziness—Apraclonidine—glaucoma	0.000667	0.00121	CcSEcCtD
Danazol—Hydrocortisone—NR3C1—glaucoma	0.000665	0.0995	CrCbGaD
Danazol—Urticaria—Dorzolamide—glaucoma	0.000657	0.00119	CcSEcCtD
Danazol—Body temperature increased—Dorzolamide—glaucoma	0.000654	0.00119	CcSEcCtD
Danazol—Tension—Betaxolol—glaucoma	0.000653	0.00119	CcSEcCtD
Danazol—Arthralgia—Clonidine—glaucoma	0.000651	0.00118	CcSEcCtD
Danazol—Anxiety—Clonidine—glaucoma	0.000649	0.00118	CcSEcCtD
Danazol—Asthenia—Acetazolamide—glaucoma	0.000647	0.00118	CcSEcCtD
Danazol—Dizziness—Bimatoprost—glaucoma	0.000647	0.00117	CcSEcCtD
Danazol—Nervousness—Betaxolol—glaucoma	0.000646	0.00117	CcSEcCtD
Danazol—Urticaria—Brinzolamide—glaucoma	0.000646	0.00117	CcSEcCtD
Danazol—Vomiting—Apraclonidine—glaucoma	0.000641	0.00116	CcSEcCtD
Danazol—Muscle spasms—Betaxolol—glaucoma	0.00064	0.00116	CcSEcCtD
Danazol—Dermatitis—Apraclonidine—glaucoma	0.000635	0.00115	CcSEcCtD
Danazol—Headache—Apraclonidine—glaucoma	0.000632	0.00115	CcSEcCtD
Danazol—Vision blurred—Betaxolol—glaucoma	0.000627	0.00114	CcSEcCtD
Danazol—Oedema—Clonidine—glaucoma	0.000624	0.00113	CcSEcCtD
Danazol—Tremor—Betaxolol—glaucoma	0.000624	0.00113	CcSEcCtD
Danazol—Asthenia—Brimonidine—glaucoma	0.000621	0.00113	CcSEcCtD
Danazol—Body temperature increased—Pilocarpine—glaucoma	0.000618	0.00112	CcSEcCtD
Danazol—Rash—Bimatoprost—glaucoma	0.000616	0.00112	CcSEcCtD
Danazol—Dermatitis—Bimatoprost—glaucoma	0.000616	0.00112	CcSEcCtD
Danazol—Shock—Clonidine—glaucoma	0.000614	0.00112	CcSEcCtD
Danazol—Pruritus—Brimonidine—glaucoma	0.000612	0.00111	CcSEcCtD
Danazol—Headache—Bimatoprost—glaucoma	0.000612	0.00111	CcSEcCtD
Danazol—Thrombocytopenia—Clonidine—glaucoma	0.000611	0.00111	CcSEcCtD
Danazol—Tachycardia—Clonidine—glaucoma	0.000609	0.00111	CcSEcCtD
Danazol—Hyperhidrosis—Clonidine—glaucoma	0.000603	0.0011	CcSEcCtD
Danazol—Visual impairment—Timolol—glaucoma	0.000602	0.00109	CcSEcCtD
Danazol—Nausea—Apraclonidine—glaucoma	0.000599	0.00109	CcSEcCtD
Danazol—Vertigo—Betaxolol—glaucoma	0.000598	0.00109	CcSEcCtD
Danazol—Syncope—Betaxolol—glaucoma	0.000597	0.00108	CcSEcCtD
Danazol—Dizziness—Acetazolamide—glaucoma	0.000596	0.00108	CcSEcCtD
Danazol—Asthenia—Dorzolamide—glaucoma	0.000593	0.00108	CcSEcCtD
Danazol—Asthenia—Travoprost—glaucoma	0.000591	0.00107	CcSEcCtD
Danazol—Palpitations—Betaxolol—glaucoma	0.000588	0.00107	CcSEcCtD
Danazol—Pruritus—Dorzolamide—glaucoma	0.000585	0.00106	CcSEcCtD
Danazol—Loss of consciousness—Betaxolol—glaucoma	0.000585	0.00106	CcSEcCtD
Danazol—Asthenia—Brinzolamide—glaucoma	0.000583	0.00106	CcSEcCtD
Danazol—Pruritus—Travoprost—glaucoma	0.000582	0.00106	CcSEcCtD
Danazol—Nausea—Bimatoprost—glaucoma	0.000581	0.00106	CcSEcCtD
Danazol—Pruritus—Brinzolamide—glaucoma	0.000575	0.00104	CcSEcCtD
Danazol—Vomiting—Acetazolamide—glaucoma	0.000573	0.00104	CcSEcCtD
Danazol—Dizziness—Brimonidine—glaucoma	0.000572	0.00104	CcSEcCtD
Danazol—Musculoskeletal discomfort—Clonidine—glaucoma	0.000568	0.00103	CcSEcCtD
Danazol—Arthralgia—Betaxolol—glaucoma	0.000567	0.00103	CcSEcCtD
Danazol—Headache—Acetazolamide—glaucoma	0.000565	0.00103	CcSEcCtD
Danazol—Anxiety—Betaxolol—glaucoma	0.000565	0.00103	CcSEcCtD
Danazol—Asthenia—Pilocarpine—glaucoma	0.00056	0.00102	CcSEcCtD
Danazol—Paraesthesia—Clonidine—glaucoma	0.00056	0.00102	CcSEcCtD
Danazol—Pruritus—Pilocarpine—glaucoma	0.000553	0.001	CcSEcCtD
Danazol—Alopecia—Timolol—glaucoma	0.000552	0.001	CcSEcCtD
Danazol—Dizziness—Dorzolamide—glaucoma	0.000547	0.000993	CcSEcCtD
Danazol—Rash—Brimonidine—glaucoma	0.000546	0.000992	CcSEcCtD
Danazol—Dermatitis—Brimonidine—glaucoma	0.000545	0.000991	CcSEcCtD
Danazol—Dizziness—Travoprost—glaucoma	0.000544	0.000989	CcSEcCtD
Danazol—Oedema—Betaxolol—glaucoma	0.000543	0.000987	CcSEcCtD
Danazol—Headache—Brimonidine—glaucoma	0.000542	0.000985	CcSEcCtD
Danazol—Progesterone—NR3C1—glaucoma	0.000542	0.081	CrCbGaD
Danazol—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.00054	0.00225	CbGpPWpGaD
Danazol—Fatigue—Clonidine—glaucoma	0.000538	0.000977	CcSEcCtD
Danazol—Dizziness—Brinzolamide—glaucoma	0.000537	0.000977	CcSEcCtD
Danazol—Nausea—Acetazolamide—glaucoma	0.000536	0.000973	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—LRP12—glaucoma	0.000535	0.00223	CbGpPWpGaD
Danazol—Shock—Betaxolol—glaucoma	0.000534	0.000971	CcSEcCtD
Danazol—Tension—Timolol—glaucoma	0.000534	0.000969	CcSEcCtD
Danazol—Constipation—Clonidine—glaucoma	0.000533	0.000969	CcSEcCtD
Danazol—Thrombocytopenia—Betaxolol—glaucoma	0.000532	0.000966	CcSEcCtD
Danazol—Tachycardia—Betaxolol—glaucoma	0.00053	0.000963	CcSEcCtD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000529	0.0022	CbGpPWpGaD
Danazol—Nervousness—Timolol—glaucoma	0.000528	0.000959	CcSEcCtD
Danazol—CCL2—TNF alpha Signaling Pathway—TNF—glaucoma	0.000527	0.00219	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000526	0.00219	CbGpPWpGaD
Danazol—Vomiting—Dorzolamide—glaucoma	0.000526	0.000955	CcSEcCtD
Danazol—Hyperhidrosis—Betaxolol—glaucoma	0.000525	0.000954	CcSEcCtD
Danazol—Rash—Dorzolamide—glaucoma	0.000521	0.000947	CcSEcCtD
Danazol—Dermatitis—Dorzolamide—glaucoma	0.000521	0.000946	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00052	0.00217	CbGpPWpGaD
Danazol—Rash—Travoprost—glaucoma	0.000519	0.000943	CcSEcCtD
Danazol—Dermatitis—Travoprost—glaucoma	0.000519	0.000942	CcSEcCtD
Danazol—Headache—Dorzolamide—glaucoma	0.000518	0.000941	CcSEcCtD
Danazol—Vomiting—Brinzolamide—glaucoma	0.000517	0.000939	CcSEcCtD
Danazol—Dizziness—Pilocarpine—glaucoma	0.000517	0.000939	CcSEcCtD
Danazol—Headache—Travoprost—glaucoma	0.000516	0.000937	CcSEcCtD
Danazol—Nausea—Brimonidine—glaucoma	0.000514	0.000934	CcSEcCtD
Danazol—Rash—Brinzolamide—glaucoma	0.000512	0.000931	CcSEcCtD
Danazol—Vision blurred—Timolol—glaucoma	0.000512	0.000931	CcSEcCtD
Danazol—Dermatitis—Brinzolamide—glaucoma	0.000512	0.00093	CcSEcCtD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.00051	0.00212	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000509	0.00212	CbGpPWpGaD
Danazol—Headache—Brinzolamide—glaucoma	0.000509	0.000925	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000498	0.00207	CbGpPWpGaD
Danazol—Vomiting—Pilocarpine—glaucoma	0.000497	0.000903	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000496	0.00207	CbGpPWpGaD
Danazol—Urticaria—Clonidine—glaucoma	0.000496	0.000901	CcSEcCtD
Danazol—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000495	0.000899	CcSEcCtD
Danazol—Body temperature increased—Clonidine—glaucoma	0.000493	0.000896	CcSEcCtD
Danazol—Rash—Pilocarpine—glaucoma	0.000493	0.000895	CcSEcCtD
Danazol—Dermatitis—Pilocarpine—glaucoma	0.000492	0.000894	CcSEcCtD
Danazol—Nausea—Dorzolamide—glaucoma	0.000491	0.000892	CcSEcCtD
Danazol—Headache—Pilocarpine—glaucoma	0.000489	0.000889	CcSEcCtD
Danazol—Nausea—Travoprost—glaucoma	0.000489	0.000888	CcSEcCtD
Danazol—Vertigo—Timolol—glaucoma	0.000488	0.000888	CcSEcCtD
Danazol—Paraesthesia—Betaxolol—glaucoma	0.000488	0.000886	CcSEcCtD
Danazol—Syncope—Timolol—glaucoma	0.000488	0.000886	CcSEcCtD
Danazol—Nausea—Brinzolamide—glaucoma	0.000483	0.000877	CcSEcCtD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000481	0.002	CbGpPWpGaD
Danazol—Palpitations—Timolol—glaucoma	0.00048	0.000873	CcSEcCtD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00048	0.002	CbGpPWpGaD
Danazol—Dyspepsia—Betaxolol—glaucoma	0.000478	0.000869	CcSEcCtD
Danazol—Loss of consciousness—Timolol—glaucoma	0.000478	0.000868	CcSEcCtD
Danazol—Hypertension—Timolol—glaucoma	0.000469	0.000853	CcSEcCtD
Danazol—Fatigue—Betaxolol—glaucoma	0.000468	0.000851	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000467	0.00194	CbGpPWpGaD
Danazol—Constipation—Betaxolol—glaucoma	0.000464	0.000844	CcSEcCtD
Danazol—Nausea—Pilocarpine—glaucoma	0.000464	0.000843	CcSEcCtD
Danazol—Arthralgia—Timolol—glaucoma	0.000463	0.000841	CcSEcCtD
Danazol—Anxiety—Timolol—glaucoma	0.000461	0.000838	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.00046	0.00192	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000459	0.00191	CbGpPWpGaD
Danazol—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000452	0.00188	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000448	0.00186	CbGpPWpGaD
Danazol—Asthenia—Clonidine—glaucoma	0.000448	0.000813	CcSEcCtD
Danazol—Oedema—Timolol—glaucoma	0.000444	0.000806	CcSEcCtD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000442	0.00184	CbGpPWpGaD
Danazol—Pruritus—Clonidine—glaucoma	0.000441	0.000802	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.00044	0.00183	CbGpPWpGaD
Danazol—Shock—Timolol—glaucoma	0.000437	0.000793	CcSEcCtD
Danazol—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000436	0.00181	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TNF—glaucoma	0.000432	0.0018	CbGpPWpGaD
Danazol—Urticaria—Betaxolol—glaucoma	0.000431	0.000784	CcSEcCtD
Danazol—Body temperature increased—Betaxolol—glaucoma	0.000429	0.00078	CcSEcCtD
Danazol—Hyperhidrosis—Timolol—glaucoma	0.000429	0.000779	CcSEcCtD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000424	0.00176	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000423	0.00176	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00042	0.00175	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000418	0.00174	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—PAX6—glaucoma	0.000416	0.00173	CbGpPWpGaD
Danazol—Dizziness—Clonidine—glaucoma	0.000413	0.00075	CcSEcCtD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.00041	0.00171	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—BAD—glaucoma	0.00041	0.00171	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—OPN4—glaucoma	0.000406	0.00169	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Timolol—glaucoma	0.000404	0.000735	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000401	0.00167	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000401	0.00167	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—EDN1—glaucoma	0.000401	0.00167	CbGpPWpGaD
Danazol—Paraesthesia—Timolol—glaucoma	0.000398	0.000724	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000397	0.00165	CbGpPWpGaD
Danazol—Vomiting—Clonidine—glaucoma	0.000397	0.000721	CcSEcCtD
Danazol—Rash—Clonidine—glaucoma	0.000393	0.000715	CcSEcCtD
Danazol—Dermatitis—Clonidine—glaucoma	0.000393	0.000714	CcSEcCtD
Danazol—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000392	0.00163	CbGpPWpGaD
Danazol—Headache—Clonidine—glaucoma	0.000391	0.00071	CcSEcCtD
Danazol—Dyspepsia—Timolol—glaucoma	0.000391	0.00071	CcSEcCtD
Danazol—Asthenia—Betaxolol—glaucoma	0.00039	0.000708	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000388	0.00162	CbGpPWpGaD
Danazol—Pruritus—Betaxolol—glaucoma	0.000384	0.000698	CcSEcCtD
Danazol—Fatigue—Timolol—glaucoma	0.000383	0.000695	CcSEcCtD
Danazol—CCL2—Spinal Cord Injury—TP53—glaucoma	0.000381	0.00159	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HEYL—glaucoma	0.000377	0.00157	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—OPN4—glaucoma	0.000371	0.00154	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000371	0.00154	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000371	0.00154	CbGpPWpGaD
Danazol—Nausea—Clonidine—glaucoma	0.000371	0.000673	CcSEcCtD
Danazol—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000369	0.00154	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—EDN1—glaucoma	0.000366	0.00153	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTGFR—glaucoma	0.000365	0.00152	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000362	0.00151	CbGpPWpGaD
Danazol—Dizziness—Betaxolol—glaucoma	0.000359	0.000653	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000358	0.00149	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000355	0.00148	CbGpPWpGaD
Danazol—Urticaria—Timolol—glaucoma	0.000352	0.00064	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000352	0.00146	CbGpPWpGaD
Danazol—Body temperature increased—Timolol—glaucoma	0.000351	0.000637	CcSEcCtD
Danazol—CCL2—GPCR ligand binding—C3—glaucoma	0.00035	0.00146	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NARFL—glaucoma	0.000349	0.00145	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA5A—glaucoma	0.000349	0.00145	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000348	0.00145	CbGpPWpGaD
Danazol—Vomiting—Betaxolol—glaucoma	0.000345	0.000627	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—HEYL—glaucoma	0.000345	0.00144	CbGpPWpGaD
Danazol—Rash—Betaxolol—glaucoma	0.000342	0.000622	CcSEcCtD
Danazol—Dermatitis—Betaxolol—glaucoma	0.000342	0.000622	CcSEcCtD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000341	0.00142	CbGpPWpGaD
Danazol—Headache—Betaxolol—glaucoma	0.00034	0.000618	CcSEcCtD
Danazol—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.00034	0.00142	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LRP12—glaucoma	0.000338	0.00141	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000336	0.0014	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTGFR—glaucoma	0.000334	0.00139	CbGpPWpGaD
Danazol—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000333	0.00139	CbGpPWpGaD
Danazol—Nausea—Betaxolol—glaucoma	0.000323	0.000586	CcSEcCtD
Danazol—GNRHR—GPCR ligand binding—C3—glaucoma	0.00032	0.00133	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.000319	0.00133	CbGpPWpGaD
Danazol—Asthenia—Timolol—glaucoma	0.000318	0.000578	CcSEcCtD
Danazol—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000317	0.00132	CbGpPWpGaD
Danazol—Pruritus—Timolol—glaucoma	0.000314	0.00057	CcSEcCtD
Danazol—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000314	0.00131	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000313	0.0013	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—SMO—glaucoma	0.000312	0.0013	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000311	0.0013	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000311	0.00129	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000304	0.00127	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000299	0.00125	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000299	0.00124	CbGpPWpGaD
Danazol—Dizziness—Timolol—glaucoma	0.000293	0.000533	CcSEcCtD
Danazol—ESR1—LKB1 signaling events—TP53—glaucoma	0.000289	0.0012	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000288	0.0012	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RPTOR—glaucoma	0.000286	0.00119	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.000285	0.00119	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—SMO—glaucoma	0.000285	0.00119	CbGpPWpGaD
Danazol—Vomiting—Timolol—glaucoma	0.000282	0.000513	CcSEcCtD
Danazol—Rash—Timolol—glaucoma	0.00028	0.000508	CcSEcCtD
Danazol—Dermatitis—Timolol—glaucoma	0.00028	0.000508	CcSEcCtD
Danazol—Headache—Timolol—glaucoma	0.000278	0.000505	CcSEcCtD
Danazol—CCL2—Signaling Pathways—NCK2—glaucoma	0.000277	0.00115	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000275	0.00115	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000274	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.00027	0.00112	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000269	0.00112	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000268	0.00112	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000266	0.00111	CbGpPWpGaD
Danazol—Nausea—Timolol—glaucoma	0.000264	0.000479	CcSEcCtD
Danazol—GNRHR—Signaling Pathways—RPTOR—glaucoma	0.000261	0.00109	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00026	0.00108	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NCK2—glaucoma	0.000253	0.00105	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000242	0.00101	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—BAD—glaucoma	0.00024	0.001	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP1—glaucoma	0.000237	0.000986	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HDAC9—glaucoma	0.000235	0.00098	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000234	0.000975	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—OPN4—glaucoma	0.000234	0.000974	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000233	0.000971	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000218	0.000908	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HEYL—glaucoma	0.000218	0.000906	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HDAC9—glaucoma	0.000215	0.000896	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTGFR—glaucoma	0.000211	0.000877	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—EDN1—glaucoma	0.000207	0.000862	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EDN1—glaucoma	0.000206	0.000856	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NR3C1—glaucoma	0.000205	0.000852	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.0002	0.000834	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LRP12—glaucoma	0.000198	0.000825	CbGpPWpGaD
Danazol—CCL2—endothelium—glaucoma	0.000196	0.279	CbGeAlD
Danazol—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000196	0.000815	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000191	0.000796	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EDN1—glaucoma	0.000188	0.000783	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SMO—glaucoma	0.000184	0.000767	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—MMP2—glaucoma	0.000183	0.000763	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000182	0.000757	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000181	0.000754	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—C3—glaucoma	0.000181	0.000753	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—C3—glaucoma	0.00018	0.000748	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000178	0.00074	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000177	0.000737	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA1—glaucoma	0.000171	0.00071	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NTRK2—glaucoma	0.000168	0.000701	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SMO—glaucoma	0.000168	0.000701	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	0.000167	0.000697	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CTSA—glaucoma	0.000165	0.000688	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RPTOR—glaucoma	0.000165	0.000686	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—C3—glaucoma	0.000164	0.000684	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NCK2—glaucoma	0.00016	0.000665	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000156	0.000651	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CA2—glaucoma	0.000156	0.000649	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NR3C1—glaucoma	0.000156	0.000649	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NTRK2—glaucoma	0.000154	0.000642	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000152	0.000635	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000152	0.000635	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—glaucoma	0.000152	0.000632	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000151	0.000627	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000147	0.000613	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000145	0.000605	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NGFR—glaucoma	0.000145	0.000602	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.00014	0.000583	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00014	0.000581	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000137	0.000572	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NTRK1—glaucoma	0.000137	0.000572	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—OPN4—glaucoma	0.000137	0.000572	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	0.000137	0.00057	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HDAC9—glaucoma	0.000136	0.000565	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGFR—glaucoma	0.000132	0.00055	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000129	0.000538	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HEYL—glaucoma	0.000128	0.000532	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN2B—glaucoma	0.000127	0.000527	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NTRK1—glaucoma	0.000126	0.000523	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTGFR—glaucoma	0.000124	0.000515	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EDN1—glaucoma	0.000121	0.000506	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	0.00012	0.0005	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000118	0.000492	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000116	0.000483	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000116	0.000482	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN2B—glaucoma	0.000116	0.000482	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000114	0.000476	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000114	0.000474	CbGpPWpGaD
Danazol—PGR—Gene Expression—CDKN2B—glaucoma	0.000112	0.000467	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NGF—glaucoma	0.000112	0.000465	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EDN1—glaucoma	0.000111	0.000462	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TXN—glaucoma	0.00011	0.000458	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMO—glaucoma	0.000106	0.000442	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—C3—glaucoma	0.000106	0.000442	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000106	0.000441	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGF—glaucoma	0.000102	0.000425	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA5A—glaucoma	0.000102	0.000424	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NARFL—glaucoma	0.000102	0.000424	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.0001	0.000418	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.94e-05	0.000414	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.93e-05	0.000414	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—glaucoma	9.88e-05	0.000411	CbGpPWpGaD
Danazol—PGR—Gene Expression—NR3C1—glaucoma	9.85e-05	0.00041	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CAV1—glaucoma	9.78e-05	0.000407	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK2—glaucoma	9.72e-05	0.000405	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—C3—glaucoma	9.7e-05	0.000404	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RPTOR—glaucoma	9.67e-05	0.000403	CbGpPWpGaD
Danazol—CCL2—eye—glaucoma	9.61e-05	0.137	CbGeAlD
Danazol—CCL2—retina—glaucoma	9.53e-05	0.135	CbGeAlD
Danazol—ESR1—Signaling Pathways—NCK2—glaucoma	9.37e-05	0.00039	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FN1—glaucoma	9.31e-05	0.000388	CbGpPWpGaD
Danazol—CCL2—connective tissue—glaucoma	9.26e-05	0.132	CbGeAlD
Danazol—CYP3A4—Biological oxidations—GSTM1—glaucoma	9.26e-05	0.000386	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BAD—glaucoma	9.2e-05	0.000383	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	9.13e-05	0.00038	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—glaucoma	9.03e-05	0.000376	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CAV1—glaucoma	8.95e-05	0.000373	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.77e-05	0.000365	CbGpPWpGaD
Danazol—AR—Gene Expression—CDKN2B—glaucoma	8.55e-05	0.000356	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTT1—glaucoma	8.52e-05	0.000355	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FN1—glaucoma	8.52e-05	0.000355	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BAD—glaucoma	8.42e-05	0.00035	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGFR—glaucoma	8.34e-05	0.000347	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HDAC9—glaucoma	7.97e-05	0.000332	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NTRK1—glaucoma	7.92e-05	0.00033	CbGpPWpGaD
Danazol—AR—Gene Expression—NR3C1—glaucoma	7.51e-05	0.000313	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOS3—glaucoma	7.4e-05	0.000308	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN2B—glaucoma	7.3e-05	0.000304	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EDN1—glaucoma	7e-05	0.000292	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.87e-05	0.000286	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCA1—glaucoma	6.79e-05	0.000283	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1B1—glaucoma	6.79e-05	0.000283	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOS3—glaucoma	6.77e-05	0.000282	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CDKN2B—glaucoma	6.59e-05	0.000274	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGF—glaucoma	6.44e-05	0.000268	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1B—glaucoma	6.41e-05	0.000267	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMO—glaucoma	6.23e-05	0.00026	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—C3—glaucoma	6.12e-05	0.000255	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—glaucoma	5.94e-05	0.000247	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1B—glaucoma	5.86e-05	0.000244	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—glaucoma	5.78e-05	0.000241	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—glaucoma	5.7e-05	0.000237	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—glaucoma	5.7e-05	0.000237	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CAV1—glaucoma	5.64e-05	0.000235	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—glaucoma	5.43e-05	0.000226	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—glaucoma	5.43e-05	0.000226	CbGpPWpGaD
Danazol—SHBG—connective tissue—glaucoma	5.4e-05	0.0768	CbGeAlD
Danazol—PGR—Signaling Pathways—FN1—glaucoma	5.37e-05	0.000224	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—glaucoma	5.33e-05	0.000222	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BAD—glaucoma	5.31e-05	0.000221	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA1—glaucoma	4.98e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGFR—glaucoma	4.89e-05	0.000204	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—glaucoma	4.87e-05	0.000203	CbGpPWpGaD
Danazol—PGR—connective tissue—glaucoma	4.87e-05	0.0692	CbGeAlD
Danazol—CYP3A4—Metabolism—CTSA—glaucoma	4.82e-05	0.000201	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—glaucoma	4.8e-05	0.0002	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK1—glaucoma	4.65e-05	0.000194	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA2—glaucoma	4.55e-05	0.00019	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—glaucoma	4.47e-05	0.000186	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAV1—glaucoma	4.42e-05	0.000184	CbGpPWpGaD
Danazol—CYP19A1—connective tissue—glaucoma	4.38e-05	0.0623	CbGeAlD
Danazol—ESR1—Signaling Pathways—CDKN2B—glaucoma	4.28e-05	0.000178	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—glaucoma	4.27e-05	0.000178	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDN1—glaucoma	4.11e-05	0.000171	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—glaucoma	4.03e-05	0.000168	CbGpPWpGaD
Danazol—AR—connective tissue—glaucoma	3.88e-05	0.0552	CbGeAlD
Danazol—ESR1—connective tissue—glaucoma	3.81e-05	0.0541	CbGeAlD
Danazol—ESR1—Signaling Pathways—NGF—glaucoma	3.78e-05	0.000157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—glaucoma	3.7e-05	0.000154	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—glaucoma	3.68e-05	0.000153	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C3—glaucoma	3.59e-05	0.00015	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—glaucoma	3.42e-05	0.000143	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—glaucoma	3.35e-05	0.000139	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—glaucoma	3.34e-05	0.000139	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CAV1—glaucoma	3.31e-05	0.000138	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TXN—glaucoma	3.21e-05	0.000134	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FN1—glaucoma	3.15e-05	0.000131	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BAD—glaucoma	3.12e-05	0.00013	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—glaucoma	3.07e-05	0.000128	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—glaucoma	3.06e-05	0.000127	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—glaucoma	2.5e-05	0.000104	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—glaucoma	2.49e-05	0.000104	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—glaucoma	2.32e-05	9.67e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—glaucoma	2.17e-05	9.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—glaucoma	2.01e-05	8.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCA1—glaucoma	1.98e-05	8.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1B1—glaucoma	1.98e-05	8.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—glaucoma	1.8e-05	7.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—glaucoma	1.58e-05	6.6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—glaucoma	1.4e-05	5.83e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—glaucoma	1.36e-05	5.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—glaucoma	1.3e-05	5.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAV1—glaucoma	1.29e-05	5.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—glaucoma	9.76e-06	4.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—glaucoma	8.93e-06	3.72e-05	CbGpPWpGaD
